U.S. Markets close in 7 mins

Avivagen Inc. (VIVXF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0666-0.0195 (-22.65%)
As of 10:23AM EST. Market open.

Avivagen Inc.

100 Sussex Drive
Ottawa, ON K1A 0R6

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees13

Key Executives

NameTitlePayExercisedYear Born
Mr. G. F. Kym AnthonyCEO & Director344.52kN/A1956
Dr. Graham Burton Ph.D.Co-Founder, Chief Scientific Officer & Director91.48kN/AN/A
Dr. James Nickerson Ph.D.Pres and Exec. VP of Bus. Devel. & Product InnovationN/AN/AN/A
Mr. Ira LevyInterim Chief Financial OfficerN/AN/AN/A
Mr. Drew BasekDirector of Investor RelationsN/AN/AN/A
Ms. Tracy Gillett BVSCDirector of Companion Animal & Marketing Mang.N/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

Corporate Governance

Avivagen Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.